Trials / Completed
CompletedNCT02089464
Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 199 (actual)
- Sponsor
- Nexstim Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A pivotal, prospective, multi-center, randomized, controlled, double-blinded study combining active Nexstim NBS-guided 1Hz rTMS or sham-rTMS targeting the healthy hemisphere with standardized task oriented rehabilitation will be conducted in patients with post-stroke motor impairment. The therapy will be provided for 6 weeks and primary outcome assessed 6 months later.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NBS-guided rTMS | |
| DEVICE | Sham rTMS | |
| PROCEDURE | Task oriented rehabilitation |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2014-03-17
- Last updated
- 2020-09-01
- Results posted
- 2020-09-01
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02089464. Inclusion in this directory is not an endorsement.